This study is developing a tool to help Spanish-speaking patients with ovarian cancer make decisions about their maintenance therapy (treatment given after initial therapy to prevent cancer from returning). The study is testing a Shared Medical Decision Tool, Engaging Patients in Decision Making, and Literacy Spanish Language approaches, all considered standard of care. You might be able to join if you are 18 or older, have advanced ovarian, fallopian tube, or primary peritoneal cancer, and are receiving or have finished platinum-based chemotherapy. The study aims to see how well this tool helps patients feel confident in their treatment choices, measured by a Decision Regret Scale questionnaire over an average of two years. The current recruitment status is unclear, and the study plans to enroll 70 participants.

Study design

This is an interventional study that plans to enroll 70 patients and clinical providers. It is not specified if it is randomized or blinded.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed through study completion, which is an average of two years, to measure decision regret.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.